Skip to main content

Danaher gets conditional S.Korean regulatory nod for $21 bln GE biopharma unit deal

South Korea's antitrust watchdog has approved Danaher Corp's proposed $21.4 billion acquisition of General Electric's biopharma division on condition that they sell certain assets to address monopoly concerns.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.